EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Attention‐deficit/hyperactivity disorder polygenic risk score and incidence of cognitive impairment in older adults: A prospective multicohort study

Douglas Teixeira Leffa, Guilherme Bauer‐Negrini, Livia Amaral, Bruna Bellaver, Pamela C. L. Ferreira, Guilherme Povala, Firoza Z. Lussier, João Pedro Ferrari‐Souza, Ann D. Cohen, Dana L. Tudorascu, Samuele Cortese, Luis Augusto Rohde, Brooke S. G. Molina, Derek Archer, Tharick A. Pascoal

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71770 ↗
AbstractBibliografische Angaben

Abstract

Abstract INTRODUCTION Preliminary evidence suggests a link between attention‐deficit/hyperactivity disorder (ADHD) and later‐life cognitive impairment. Whether genetic risk for ADHD, estimated using an ADHD polygenic risk score (ADHD‐PRS), is associated with incident cognitive impairment (mild cognitive impairment or Alzheimer's disease dementia) remains unknown. METHODS We analyzed 7761 cognitively unimpaired (CU) older adults with whole‐genome sequencing from eight cohorts participating in the Alzheimer's Disease Sequencing Project (ADSP). RESULTS During follow‐up, 1347 participants developed cognitive impairment. Ten‐year cumulative incidence was 33.8% in the highest ADHD‐PRS tertile versus 23.4% in the lowest. In Cox models, higher ADHD‐PRS remained associated with greater risk of cognitive impairment after adjustment for education, apolipoprotein E ( APOE) ε4 status, or vascular risk. PRSs for other major psychiatric disorders were not associated with cognitive impairment in the same analytic framework. In a subsample with biomarker data, the association was not modified by baseline amyloid‐β status. DISCUSSION These findings support ADHD‐PRS as a novel correlate of cognitive impairment and vulnerability in aging.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →